Pharma consultancy sold to French firm

Callisto, a leading UK pharmaceutical consultancy, has been sold to ProductLife Group (PLG) in a deal advised upon by Jay Singh, KBS corporate finance director.

Founded in 2003, Callisto is headquartered in Lockington, Leicestershire and with a second office close to Dublin Airport.

Specialising in regulatory affairs, pharmacovigilance and GMDP (good manufacturing and distribution practice) services in multiple regulated sectors, Callisto serves more than 100 clients.

The sectors in which Callisto operates include human, veterinary and herbal medicines, food supplements, medical devices, biocides and borderline products.

PLG offers regulatory, scientific, compliance and digital transformation consulting services for the life sciences industry.

“This partnership marks a new important milestone in our growth journey,” said Joanne Bunyan, managing director and a co-founder of Callisto.

She added: “As Callisto integrates with PLG, we are forging a powerful alliance in the regulatory arena, bringing our regulatory, GMP and compliance expertise to a broader audience, while still delivering high-quality service to our clients in the UK and Europe.”

Xavier Duburcq, CEO of PLG, added: “PLG and Callisto joining forces offers great potential to our complementary client bases and will contribute to the successful development of our operations and business in the UK.

“Our positive cultures and values are very well-matched and expanding PLG in this region with the similarly motivated team at Callisto should bring exciting opportunities for all.”

KBS Corporate’s Jay Singh said: “Jo has built up an exceptional business that has an excellent reputation in the market.

“Becoming part of PLG allows the business to access international markets and strengthens PLG’s offering, particularly in the UK.

“Furthermore, the transaction ensures the ongoing development of Callisto and offers its staff growth opportunities with PLG.

“It was a pleasure to advise Jo and the team and I wish them every success in the future.”

Close